Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria
Status unconfirmed · Phase 1 · Has a placebo group
Conditions studied: Healthy, Enteric Hyperoxaluria
In brief
This Phase 1, first-in-human, randomized, double-blinded, placebo controlled study is evaluating FB-001 in healthy volunteers (Part 1) and participants diagnosed with enteric hyperoxaluria (Part 2). Eligible participants receive investigational product and undergo safety monitoring, evaluations and subsequent follow-up after investigational product administration.
Key facts
- Study ID
- NCT05650112
- Run by
- Federation Bio Inc.
- People needed
- 48
- Starts
- 2022-11-16
- Expected to finish
- 2024-08-31
- Last updated by the study team
- 2023-01-25
Who can join
Age: 18 and older, up to 74. Sex: any. Healthy volunteers: accepted.
Where it is running
- Medpace Clinical Pharmacology Unit — Cincinnati, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.